Krishnendu Gupta

Krishnendu Gupta

Auto-generated profile, based on publicly available information

Krishnendu Gupta

Department of Obstetrics and Gynaecology Vivekananda Institute of Medical Sciences, Ramakrishna Mission Seva Pratishthan Kolkata India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
KGKrishnendu Gupta
Krishnendu Gupta
RMRanajit Mandal
Ranajit Mandal
PCPuja Chatterjee
Puja Chatterjee

15 February 2024 in The Journal of Obstetrics and Gynecology of India
Verified
Journal Article
Closed access
PDF file
KGKrishnendu Gupta
Krishnendu Gupta

29 October 2024 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
KTKa Yu Tse
Ka Yu Tse
ATAi Ling Tan
Ai Ling Tan
KSKirtipal Subedi
Kirtipal Subedi
SPShahana Pervin
Shahana Pervin
KGKrishnendu Gupta
Krishnendu Gupta
CPChristia Padolina
Christia Padolina
Cervical cancer remains a disease burden in Asia. The Asia and Oceania Federation of Obstetrics and Gynecology envisages a need to produce a set of recommendations on the implementation of human papilloma virus vaccination program for both lower‐middle‐income countries (LMICs) and high‐income countries (HICs), with an attempt to harmonize the practices yet allow flexibility to cater for different cultures, religions, needs and background of individual countries/cities. International guidelines and literature were sought, and recommendations were made in seven selected areas, including (i) the target groups for vaccination, (ii) the doses of vaccination including the use of single‐dose vaccination, (iii) the types of vaccines, (iv) suggestions for special populations including those with previous HPV infection, human immunodeficiency virus carriers, and lesbian, gay, bisexual, transgender, questioning/queer group, (v) inter‐changeability and the need of revaccination/booster, (vi) novel technologies and vaccines, and (vii) public education.

10 April 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
URU. D. P. Ratnasiri
U. D. P. Ratnasiri
PLPisake Lumbiganon
Pisake Lumbiganon
JTJohn Tait
John Tait
RHRohana Haththotuwa
Rohana Haththotuwa
KGKrishnendu Gupta
Krishnendu Gupta

26 July 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
UJUnnop Jaisamrarn
Unnop Jaisamrarn
PLPisake Lumbiganon
Pisake Lumbiganon
RHRohana Haththotuwa
Rohana Haththotuwa
JLJiayu Li
Jiayu Li
AOAlyssa L. Olson
Alyssa L. Olson
JTJohn David Tait
John David Tait

29 October 2024 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
KGKrishnendu Gupta
Krishnendu Gupta